Dasatinib population pharmacokinetics in patients with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (ph plus all)

被引：0
作者：
Dai, Guowei [1 ]
Roy, Amit [1 ]
Mandava, Mohan [1 ]
Blackwood-Chirchir, Anne [1 ]
Luo, Roger [1 ]
Wu, Chiyuan [1 ]
Pfister, Marc [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ 08543 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
100
引用
收藏
页码：1085 / 1085
页数：1
相关论文
共 50 条
  • [1] Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive (PH plus ) Chronic Myeloid Leukemia (CML) or PH plus Acute Lymphoblastic Leukemia (ALL): a Pharmacokinetic Study
    Hijiya, Nobuko
    Zwaan, C. Michel
    Rizzari, Carmelo
    Foa, Roberto
    Abbink, Floor
    Lancaster, Donna
    Landman-Parker, Judith
    Millot, Frederic
    Moppett, John
    Nelken, Brigitte
    Ducassou, Stephane
    Putti, Maria Caterina
    Tian, Xianbin
    Sinclair, Karen
    Santanastasio, Helene
    Buchbinder, Aby
    Kearns, Pamela
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S34 - S34
  • [2] SAFETY AND TOLERABILITY OF DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL): POOLED ANALYSIS OF OVER 2400 PATIENTS
    Saglio, G.
    le Coutre, P.
    Cortes, J.
    Mayer, J.
    Rowlings, P.
    Subar, M.
    Preston, J.
    Shah, N.
    HAEMATOLOGICA, 2014, 99 : 329 - 329
  • [3] Dasatinib - In chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
    Keam, Susan J.
    BIODRUGS, 2008, 22 (01) : 59 - 69
  • [4] Spotlight on dasatinib in chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
    McCormack P.L.
    Keam S.J.
    BioDrugs, 2012, 26 (1) : 61 - 64
  • [5] Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    McCormack, Paul L.
    Keam, Susan J.
    BIODRUGS, 2012, 26 (01) : 61 - 64
  • [6] Combination of the Hypercvad Regimen with Dasatinib in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) or Lymphoid Blast Phase of Chronic Myeloid Leukemia (CML-LB)
    Liu-Dumlao, Theresa
    O'Brien, Susan
    Cortes, Jorge E.
    Thomas, Deborah A.
    Faderl, Stefan
    Jabbour, Elias
    Koller, Charles
    Garris, Rebecca
    Kebriaei, Partow
    Champlin, Richard
    Borthakur, Gautam
    Ferrajoli, Alessandra
    Kantarjian, Hagop M.
    Ravandi, Farhad
    BLOOD, 2011, 118 (21) : 1106 - 1106
  • [7] Outcome of Patients with Chronic Myeloid Leukemia in Lymphoid Blast Crisis (CML-LBC) and Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) Treated with Hyper-CVAD and Dasatinib
    Morita, Kiyomi
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Sasaki, Koji
    Jain, Nitin
    Konopleva, Marina
    Short, Nicholas J.
    Takahashi, Koichi
    Khouri, Rita
    Nasnas, Patrice
    DiNardo, Courtney D.
    Kadia, Tapan M.
    Garcia-Manero, Guillermo
    Daver, Naval
    Bravo, Guillermo Montalban
    Issa, Ghayas C.
    Cortes, Jorge E.
    Jabbour, Elias
    BLOOD, 2020, 136
  • [8] Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Hijiya, Nobuko
    Zwaan, C. Michel
    Rizzari, Carmelo
    Foa, Robin
    Abbink, Floor
    Lancaster, Donna
    Landman-Parker, Judith
    Millot, Frederic
    Moppett, John
    Nelken, Brigitte
    Putti, Maria Caterina
    Tian, Xianbin
    Sinclair, Karen
    Santanastasio, Helene
    Buchbinder, Aby
    Kearns, Pamela
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 812 - 820
  • [9] Combination of the Hypercvad Regimen with Dasatinib Is Effective in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LB).
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Cortes, Jorge
    Thomas, Deborah A.
    Faderl, Stefan
    Jones, Dan
    Jabbour, Elias
    Koller, Charles
    Dara, Samuel
    Garris, Rebecca
    Kebriaei, Partow
    Borthakur, Gautam
    Ferrajoli, Alessandra
    O'Brien, Susan
    BLOOD, 2009, 114 (22) : 806 - 807
  • [10] Impact of Polymorphisms in Pharmacokinetic Genes on Tyrosine Kinase Inhibitor (TKI) Tolerability in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Patel, Jai N.
    Lopes, Karine Eboli
    Druhan, Lawrence J.
    Zeng, Hang
    Beam, Travis
    Moore, Donald C.
    Salem, Ahmed
    Hamadeh, Issam
    Savage, Quanisha
    Chojecki, Aleksander L.
    Ai, Jing
    Knight, Thomas G.
    Ragon, Brittany Knick
    Shah, Nilay A.
    Sanikommu, Srinivasa Reddy
    Steuerwald, Nury M.
    Smith, Mathew
    Hamilton, Alicia
    Rangavajhula, Keerthana
    Bell, Ariel
    Drummond, Kendra
    Symanowski, James T.
    Grunwald, Michael R.
    BLOOD, 2022, 140 : 11530 - 11531
12345